181 related articles for article (PubMed ID: 19368208)
21. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
Bessen RA; Raymond GJ; Caughey B
J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
[TBL] [Abstract][Full Text] [Related]
22. Biodegradation of prions in compost.
Xu S; Reuter T; Gilroyed BH; Mitchell GB; Price LM; Dudas S; Braithwaite SL; Graham C; Czub S; Leonard JJ; Balachandran A; Neumann NF; Belosevic M; McAllister TA
Environ Sci Technol; 2014 Jun; 48(12):6909-18. PubMed ID: 24819143
[TBL] [Abstract][Full Text] [Related]
23. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
[TBL] [Abstract][Full Text] [Related]
24. Defining and Assessing Analytical Performance Criteria for Transmissible Spongiform Encephalopathy-Detecting Amyloid Seeding Assays.
Gray JG; Graham C; Dudas S; Paxman E; Vuong B; Czub S
J Mol Diagn; 2016 May; 18(3):454-467. PubMed ID: 27068712
[TBL] [Abstract][Full Text] [Related]
25. The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species.
Wiseman FK; Cancellotti E; Piccardo P; Iremonger K; Boyle A; Brown D; Ironside JW; Manson JC; Diack AB
J Virol; 2015 May; 89(9):4738-47. PubMed ID: 25673720
[TBL] [Abstract][Full Text] [Related]
26. Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP.
Somerville RA
J Gen Virol; 1999 Jul; 80 ( Pt 7)():1865-1872. PubMed ID: 10423157
[TBL] [Abstract][Full Text] [Related]
27. Prion protein and the molecular features of transmissible spongiform encephalopathy agents.
Silveira JR; Caughey B; Baron GS
Curr Top Microbiol Immunol; 2004; 284():1-50. PubMed ID: 15148986
[TBL] [Abstract][Full Text] [Related]
28. Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.
Khadka A; Spiers JG; Cheng L; Hill AF
Cell Tissue Res; 2023 Apr; 392(1):247-267. PubMed ID: 35394216
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of transmissible spongiform encephalopathies.
Weber T; Aguzzi A
Intervirology; 1997; 40(2-3):198-212. PubMed ID: 9450236
[TBL] [Abstract][Full Text] [Related]
30. Prion protein interconversions.
Caughey B
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
[TBL] [Abstract][Full Text] [Related]
31. Agent-specific Shadoo responses in transmissible encephalopathies.
Miyazawa K; Manuelidis L
J Neuroimmune Pharmacol; 2010 Mar; 5(1):155-63. PubMed ID: 20112073
[TBL] [Abstract][Full Text] [Related]
32. Oral transmissibility of prion disease is enhanced by binding to soil particles.
Johnson CJ; Pedersen JA; Chappell RJ; McKenzie D; Aiken JM
PLoS Pathog; 2007 Jul; 3(7):e93. PubMed ID: 17616973
[TBL] [Abstract][Full Text] [Related]
33. Species barriers in prion diseases--brief review.
Moore RA; Vorberg I; Priola SA
Arch Virol Suppl; 2005; (19):187-202. PubMed ID: 16355873
[TBL] [Abstract][Full Text] [Related]
34. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
35. Pathological prion protein in muscles of hamsters and mice infected with rodent-adapted BSE or vCJD.
Thomzig A; Cardone F; Krüger D; Pocchiari M; Brown P; Beekes M
J Gen Virol; 2006 Jan; 87(Pt 1):251-254. PubMed ID: 16361438
[TBL] [Abstract][Full Text] [Related]
36. Prion protein and species barriers in the transmissible spongiform encephalopathies.
Priola SA
Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
[TBL] [Abstract][Full Text] [Related]
37. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE?
Purdey M
Med Hypotheses; 2000 Feb; 54(2):278-306. PubMed ID: 10790765
[TBL] [Abstract][Full Text] [Related]
38. Elevated silver, barium and strontium in antlers, vegetation and soils sourced from CWD cluster areas: do Ag/Ba/Sr piezoelectric crystals represent the transmissible pathogenic agent in TSEs?
Purdey M
Med Hypotheses; 2004; 63(2):211-25. PubMed ID: 15236778
[TBL] [Abstract][Full Text] [Related]
39. Prion agent diversity and species barrier.
Béringue V; Vilotte JL; Laude H
Vet Res; 2008; 39(4):47. PubMed ID: 18519020
[TBL] [Abstract][Full Text] [Related]
40. Human transmissible spongiform encephalopathies: historic view.
Asher DM; Gregori L
Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
